Herpes zoster virus of shingles
About us We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer.
Read morePress releases
- GSK joins forces with the University of California to advance genomic research and improve drug discovery
- GSK announces data on anti-BCMA antibody-drug conjugate in patients with relapsed/refractory multiple myeloma to be presented at European Hematology Association (EHA) Congress
- Nucala (mepolizumab) gains FDA approval for two new self-administration options
Tweets from GSK
-
GSK @GSK
Meet Jilcia Johnson a biopharmaceutical investigator at our Rockville manufacturing site – go #BehindTheScience to find out about the role she plays in bringing new medicines to market #FacesOfGSK #EHA24
about 11 hours ago -
GSK @GSK
We’re committed to helping patients with immune-mediated diseases by addressing the challenges that still exist for lupus. The ‘Vision for lupus’ report highlights calls for action to help improve the lives of lupus patients. Find out more... #EULAR2019
about 15 hours ago -
GSK @GSK
Can daily tools help us understand the impact of #lupus? Duane Peters from @LupusOrg shares his thoughts. #EULAR2019
about 17 hours ago
